secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-10-07T23:59:59+00:00
Accession:  0001493152-22-027885
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio shareholders approve reverse stock split (1:10-1:50) and warrant issuance of up to 110.4M shares
--------------------------------------------------------------------------------

- Reverse split ratio range 1-for-10 to 1-for-50 approved at Oct 4 special meeting; 45.2M votes for, 2.9M against.
- Issuance of up to 110.4M shares upon exercise of Series 1 and 2 warrants approved at Oct 6 meeting; 5.5M for, 4.0M against.
- Authorized share reduction from 300M to 280M approved at Oct 6 meeting; 11.5M votes for, 1.2M against.
- Reverse split must be effected before 2023 annual meeting; exact ratio set by Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/0001493152-22-027885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-027885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer